Skip to content
ClinicalThe bonding hormone for trust and connection

Oxytocin Acetate

Also indexed as OXT, Pitocin, Love Hormone, Bonding Hormone

Oxytocin Acetate is the acetate salt form of oxytocin, a naturally occurring nonapeptide hormone synthesized in the hypothalamus and released by the posterior pituitary gland. It plays central roles in social bonding, trust, stress reduction, sexual function, and uterine contraction. Research has expanded its potential applications to include anxiety reduction, prosocial behavior enhancement, and modulation of the hypothalamic-pituitary-adrenal (HPA) axis.

Overview

Peripherally, OXTRs on uterine myometrium mediate contraction via elevated intracellular calcium; similar receptors on cardiomyocytes exhibit cardioprotective effects via anti-inflammatory NF-κB suppression. Centrally, paraventricular nucleus (PVN) oxytocinergic projections modulate the HPA axis, suppressing CRH release and attenuating cortisol output. Intranasal OXT demonstrates regional CNS effects within 8–15 minutes, with measurable CSF concentration changes preceding plasma changes, supporting direct nose-to-brain transport via perineural and perivascular pathways.

Proposed mechanism

Oxytocin binds to G-protein-coupled oxytocin receptors (OXTRs) expressed throughout the brain and peripheral tissues, triggering intracellular signaling cascades involving phospholipase C, IP3, and elevated intracellular calcium. In the central nervous system, it modulates dopaminergic and serotonergic neurotransmission to produce anxiolytic and prosocial effects. Peripherally, it stimulates smooth muscle contraction in the uterus and mammary glands, and modulates autonomic nervous system tone to reduce cortisol and blood pressure.

What the evidence supports

Randomised controlled trial data in humans exists and supports use in specific contexts.

Graded Clinical

Findings supported by randomised, controlled trials in humans, with pre-registered endpoints and published results.

Key citations

Representative primary sources, including results that did not favour the compound.

  1. [1]

    Oxytocin increases trust in humans

    · Nature, Kosfeld et al., doi:10.1038/nature03701 · 2005

  2. [2]

    Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorder: a randomized controlled trial

    · Molecular Psychiatry, Anagnostou et al. · 2012

  3. [3]

    Oxytocin treatment in children and adolescents with autism spectrum disorder (NEJM trial)

    · New England Journal of Medicine, Sikich et al., doi:10.1056/NEJMoa2103583 · 2021

  4. [4]

    Central oxytocin and social behavior

    · Nature Reviews Neuroscience, Meyer-Lindenberg et al. · 2012

  5. [5]

    The role of oxytocin in the etiology and treatment of depressive disorders

    · Brain Research, Cochran et al., doi:10.1016/j.brainres.2017.02.010 · 2017

Citation records in this build are illustrative placeholders for the design.

Reference information for research purposes. Not medical advice, and not a recommendation to use any compound. Many entries describe substances that are not approved for human use.

Related profiles

ACTH 1-39

Clinical

Full-length adrenal hormone with broad receptor activity

ACTH 1-39 is the full-length, biologically active form of adrenocorticotropic hormone, a 39-amino acid peptide naturally secreted by the anterior pituitary gland. It primarily stimulates the adrenal cortex to produce cortisol, aldosterone, and adrenal androgens. Beyond adrenal signaling, ACTH 1-39 exerts direct effects on the brain, immune system, and peripheral tissues via melanocortin receptors.

0 RCT · 0 human · 0 preclinical

Immune

Adamax

Anecdotal

Nootropic peptide blend for cognition and mood

Adamax is a research peptide blend reported to combine nootropic and neuroprotective peptide components aimed at enhancing cognitive function, mood stability, and neural recovery. It is marketed primarily for its potential effects on dopaminergic and serotonergic signaling pathways. Evidence is largely limited to preclinical and anecdotal sources, with no published human clinical trials specific to the Adamax formulation.

0 RCT · 0 human · 0 preclinical

cognition

ARA290 (Cibinetide)

Human-limited

Tissue-protective peptide for nerve repair and inflammation

ARA290, also known as Cibinetide, is a synthetic 11-amino acid peptide derived from the helix B surface peptide of erythropoietin (EPO) that selectively activates the innate repair receptor (IRR) without stimulating erythropoiesis. It is designed to harness the tissue-protective and anti-inflammatory properties of EPO while avoiding its hematopoietic side effects. Clinically, it has been investigated for neuropathic pain, small fiber neuropathy, and inflammatory conditions such as sarcoidosis.

0 RCT · 0 human · 0 preclinical

Immune